title: Advanced cardiac life support antiarrhythmic drugs.
abstract: As exemplified in this discussion of ACLS antiarrhythmic drugs, the evidence-based evaluation process has created a high standard for the acceptance and ranking of therapies for cardiac arrest. This process also has identified critical areas needing further investigation, fostered a healthy sense of discomfort with the adequacy of our present interventions for cardiac arrest, and hopefully will continue to spur the science while sifting the dogma out of CPR.
authors.affiliation: Division of Cardiology, Department of Medicine, University of Washington, Seattle, Washington, USA.
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Kudenchuk
mesh_terms: D000638:Amiodarone / Q000008:administration & dosage; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage*; D001949:Bretylium Compounds / Q000008:administration & dosage; D016887:Cardiopulmonary Resuscitation / Q000379:methods; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006323:Heart Arrest / Q000188:drug therapy* / Q000628:therapy; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage; D008020:Life Support Care / Q000379:methods*; D008274:Magnesium / Q000008:administration & dosage; D008297:Male; D011342:Procainamide; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D008012:Lidocaine; D008274:Magnesium; D011342:Procainamide; D000638:Amiodarone; C045166:bretylium